Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

Thymulin cycle length: what human studies ran

Not approved — research use onlyCPreclinical research
Short answer: there is no established Thymulin cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Thymulin combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Thymulin cycle length?
No. We found no human studies that report a treatment duration for Thymulin.
What is the longest human study of Thymulin?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
Thymulin dosing reference Full research page

References

  1. Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy Nat Commun. 2026
  2. A zinc-dependent epitope on the molecule of thymulin, a thymic hormone Proc Natl Acad Sci U S A. 1985
  3. Comparison of Thymulin Activity with Other Measures of Marginal Zinc Deficiency Biol Trace Elem Res. 2021
  4. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium Mol Immunol. 2009
  5. Prenatal and childhood exposures are associated with thymulin concentrations in young adolescent children in rural Nepal J Dev Orig Health Dis. 2020
  6. Physiology and therapeutic potential of the thymic peptide thymulin Curr Pharm Des. 2014
  7. Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways Int Immunopharmacol. 2019
  8. Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation PLoS One. 2018
  9. Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma Sci Adv. 2020
  10. NMR study of a lymphocyte differentiating thymic factor. An investigation of the Zn(II)-nonapeptide complexes (thymulin) J Biol Chem. 1988
  11. Thymulin (CID 71300623) PubChem. 2026
  12. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026): "Thymulin acetate" appears in Category 3, substances nominated without adequate support FDA. 2026
  13. Drugs@FDA application data queried through openFDA for thymulin (no matching application record returned on 24 October 2026) openFDA / Drugs@FDA. 2026
  14. International Standard: Prohibited List 2026 World Anti-Doping Agency. 2026